NMN−

3-carbamoyl-1-(5-O-phosphonato-β-D-ribofuranosyl)pyridinium

DAYLJWODMCOQEW-TURQNECASA-M CHEBI:14649 10 Reactome links 1 studies

1 Observed studies

1 Observed diff profiles

10 Reactome pathways

Metabolite details

Identifier: DAYLJWODMCOQEW-TURQNECASA-M
InChI Key: DAYLJWODMCOQEW-TURQNECASA-M
IUPAC name: 3-carbamoyl-1-(5-O-phosphonato-β-D-ribofuranosyl)pyridinium
Preferred name: NMN−
INN name: —
Synonym: —
ChEBI: CHEBI:14649

Reactome pathways

R-HSA-1430728 - Metabolism
R-HSA-1643685 - Disease
R-HSA-196807 - Nicotinate metabolism
R-HSA-196849 - Metabolism of water-soluble vitamins and cofactors
R-HSA-196854 - Metabolism of vitamins and cofactors
R-HSA-5663205 - Infectious disease
R-HSA-9658195 - Leishmania infection
R-HSA-9660826 - Purinergic signaling in leishmaniasis infection
R-HSA-9664424 - Cell recruitment (pro-inflammatory response)
R-HSA-9824443 - Parasitic Infection Pathways

Observed in studies

Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release

Observed in differential profiles

Control_16.6_months_vs_Treatment_16.6_months